Clinical Trial Update: PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae [NA]

View source ↗

Summary

Clinical trial update on the pneumococcal conjugate vaccine 7-valent (PCV7) assessing its impact on preventing nasopharyngeal carriage of vaccine-type Streptoco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Pneumonia

Drugs mentioned

• Prevnar 7 (Pneumococcal conjugate vaccine, 7-valent)

Snippet

Sponsor: Centers for Disease Control and Prevention, China | Conditions: Streptococcal Pneumonia, Nasopharyngeal Diseases | NA | Status: COMPLETED